Hybrid

Dutch Treat | Cannabis Strain Review & Effects

Also known as: Dutch Treat Haze

Northern Lights × Haze

Dutch Treat is a hybrid strain (Northern Lights × Haze) with THC levels of 18-25%. It features a Terpinolene-dominant terpene profile and is known for euphoric and relaxed. Best used during the afternoon.

THC

18-25%

CBD

0.1-0.3%

Best Time

Afternoon

Primary Effects

EuphoricRelaxedCreativeUplifted

Flavor Notes

Pine, Sweet, Eucalyptus, Earthy

Aroma

Sweet pine with eucalyptus freshness and earthy candy notes

Research Sources

26 peer-reviewed studies

Verified Via

PubMed / DOI

Evidence

Research-Backed

Updated

December 2025

Every claim cites peer-reviewed research
How We Research

What is Dutch Treat?

Dutch Treat is a hybrid strain (Northern Lights × Haze) with THC levels of 18-25%. It features a Terpinolene-dominant terpene profile and is known for euphoric and relaxed. Best used during the afternoon.

About Dutch Treat Strain

Dutch Treat is a classic Amsterdam hybrid that combines Northern Lights with Haze genetics. Known for its balanced effects and sweet, piney flavor, it delivers mental euphoria alongside physical relaxation without sedation. A staple in Pacific Northwest dispensaries.

Related Reading

Terpene Profile

Terpinolenedominant
Fresh, piney, floral, with citrus and herbal notes~0.55%

Primary research: Sedative (in isolation)

Myrceneprimary
Earthy, musky, clove-like~0.42%

Primary research: Sedation & Relaxation

Pinenesecondary
Fresh pine, forest, evergreen~0.28%

Primary research: Mental Clarity

Concentration Levels

Dominant (>1.0%)
Primary (0.5-1.0%)
Secondary (0.1-0.5%)
Trace (<0.1%)

Cannabinoid Profile

THCPsychoactive

18-25%

Pain Relief

0.1-0.3%

Seizure Reduction

Therapeutic Profile Matches

Based on Dutch Treat's terpene and cannabinoid profile, it may be well-suited for these therapeutic applications:

migraines

53%
Moderate Match
  • High myrcene content supports migraines & headaches
  • thc dominant ratio matches profile
  • Best used afternoon, aligning with condition needs

Match scores are theoretical

These scores are based on terpene/cannabinoid research and do not guarantee specific effects. Individual responses vary significantly. Always consult a healthcare provider.

  1. 1

    Ito K, Ito M. The sedative effect of inhaled terpinolene in mice and its structure-activity relationships Journal of Natural Medicines. 2013

    Terpinolene prolonged sleep time in mice.

  2. 2

    Grassmann J, et al. The monoterpene terpinolene from the oil of Pinus mugo L. in concert with alpha-tocopherol and beta-carotene effectively prevents oxidation of LDL Phytomedicine. 2005

    Terpinolene showed strong antioxidant activity.

  3. 3

    Surendran S, et al. Myrcene-What Are the Potential Health Benefits of This Flavouring and Aroma Agent? Frontiers in Nutrition. 2021

    Comprehensive review: β-myrcene may potentiate the anti-nociceptive properties of cannabinoids.

  4. 4

    Johnson MB, et al. The Effects of β-myrcene on Simulated Driving and Divided Attention: A Double-Blind, Placebo-Controlled, Crossover Pilot Study Cannabis. 2023

    Found myrcene alone did not significantly impair simulated driving performance.

  5. 5

    do Vale TG, et al. Central effects of citral, myrcene and limonene, constituents of essential oil chemotypes from Lippia alba (Mill.) n.e. Brown Phytomedicine. 2002

    Demonstrated dose-dependent sedative and motor-relaxant effects of myrcene in mice.

  6. 6

    Lorenzetti BB, et al. Myrcene mimics the peripheral analgesic activity of lemongrass tea Journal of Ethnopharmacology. 1991

    Found peripheral analgesic activity in animal models.

  7. 7

    Liktor-Busa E, et al. Analgesic Potential of Terpenes Derived from Cannabis sativa Pharmacological Reviews. 2021

    Comprehensive review of cannabis terpene analgesic effects including myrcene.

  8. 8

    Perry NS, et al. In-vitro inhibition of human erythrocyte acetylcholinesterase by salvia lavandulaefolia essential oil and constituent terpenes Journal of Pharmacy and Pharmacology. 2000

    Pinene and other terpenes inhibit AChE with memory implications.

  9. 9

    Ding Y, et al. Eucalyptol, limonene and pinene enteric capsules attenuate airway inflammation and obstruction in lipopolysaccharide-induced chronic bronchitis rat model via TLR4 signaling inhibition Phytomedicine. 2024

    Pinene attenuates airway inflammation and obstruction.

  10. 10

    Nam SY, et al. The therapeutic efficacy of α-pinene in an experimental mouse model of allergic rhinitis International Immunopharmacology. 2014

    α-Pinene reduced IgE-mediated allergic inflammation.

  11. 11

    Salehi B, et al. Therapeutic Potential of α- and β-Pinene: A Miracle Gift of Nature Biomolecules. 2019

    Most comprehensive review of pinene pharmacology.

  12. 12

    Gaoni Y, Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish Journal of the American Chemical Society. 1964. doi:10.1021/ja01062a046

    Landmark paper first identifying and synthesizing THC.

  13. 13

    Whiting PF, et al. Cannabinoids for medical use: A systematic review and meta-analysis JAMA. 2015

    Comprehensive review finding moderate evidence for chronic pain.

  14. 14

    Aviram J, Samuelly-Leichtag G. Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Pain Physician. 2017

    Systematic review of clinical trials for neuropathic pain.

  15. 15

    Lutge EE, et al. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS Cochrane Database of Systematic Reviews. 2013

    Systematic review of cannabis for HIV/AIDS symptoms including appetite.

  16. 16

    Smith LA, et al. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy Cochrane Database of Systematic Reviews. 2015

    High-quality evidence for CINV efficacy.

  17. 17

    Kesner AJ, Lovinger DM. Cannabinoids, Endocannabinoids and Sleep Frontiers in Molecular Neuroscience. 2020

    Review of THC effects on sleep architecture.

  18. 18

    Novotna A, et al. A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis European Journal of Neurology. 2011

    Phase III trial showing efficacy for MS spasticity.

  19. 19

    Silvestro S, et al. Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease Molecules. 2020

    Comprehensive review of CBD's therapeutic applications and molecular targets.

  20. 20

    Thiele EA, et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial Lancet. 2018

    Phase III trial leading to FDA approval of Epidiolex.

  21. 21

    Devinsky O, et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial Lancet Neurology. 2016

    Open-label trial showing 36.5% reduction in seizures.

  22. 22

    Shannon S, et al. Cannabidiol in anxiety and sleep: A large case series Permanente Journal. 2019

    79.2% of patients reported reduced anxiety within first month.

  23. 23

    Bergamaschi MM, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients Neuropsychopharmacology. 2011

    CBD reduced anxiety in simulated public speaking test.

  24. 24

    Burstein S. Cannabidiol (CBD) and its analogs: a review of their effects on inflammation Bioorganic & Medicinal Chemistry. 2015

    Review of CBD's anti-inflammatory mechanisms.

  25. 25

    Shannon S, et al. Cannabidiol in Anxiety and Sleep: A Large Case Series Permanente Journal. 2019

    66.7% of patients reported improved sleep in this anxiety and sleep study.

  26. 26

    Urits I, et al. Use of cannabidiol (CBD) for the treatment of chronic pain Best Practice & Research Clinical Anaesthesiology. 2020

    Comprehensive review of CBD for chronic pain management.

Research Verification

All citations link directly to PubMed or the original source. You can verify any claim by clicking the reference link. Learn more about how we research.

Frequently Asked Questions

Why is Dutch Treat popular in the Pacific Northwest?

Dutch Treat became a staple in the Pacific Northwest, especially Seattle, where it was refined and popularized. The climate suits its growth, and local cultivators perfected the genetics.

Is Dutch Treat indica or sativa?

Dutch Treat is a balanced hybrid that leans slightly indica in effects. It provides mental euphoria with body relaxation but without heavy sedation.

Quick Facts

Type
Hybrid
Genetics
Northern Lights × Haze
Breeder
Amsterdam
Best Time of Use
Afternoon
Availability
common
Grow Difficulty
easy

Want to try Dutch Treat? Get your medical marijuana card today.

Get Your Card

Educational Information

This content is for educational purposes only and is not medical advice. Consult a healthcare provider before using cannabis products.

Strain Variability

Profiles vary between batches, growers, and growing conditions. Always check lab test results for the specific product you're purchasing.

Beyond Indica/Sativa

Effects are better predicted by cannabinoid and terpene profiles than strain classification. Focus on the chemistry, not the label.

Understanding Therapeutic Profiles

Learn how terpenes and cannabinoids work together to create each strain's unique effects and therapeutic potential through the entourage effect.

Learn About Therapeutic Profiles